Hungry bone syndrome occurs in 1 of 5 patients after parathyroidectomy for secondary hyperparathyroidism of renal origin, a study found.
Magnesium homeostasis in CKD-MBD been the subject of increasing attention because it plays an important role in the pathophysiology of cardiovascular disease and bone health, according to investigators.
Paricalcitol and/or calcimimetic use is associated with improved survival in patients with COVID-19 receiving maintenance hemodialysis, a study found.
The medication inhibits bone resorption but is associated with prolonged elevation in PTH levels that require treatment.
Study is the largest to explore this potential safety issue to date.
The review was based on 198 scientific references.
Neutrophil gelatinase-associated lipocalin (NGAL) is not only a biomarker of kidney injury but also a bone-derived factor involved in metabolism.
Take the quiz on this clinical case: Which of the following is NOT associated with non-uremic calciphylaxis?
In a cross-sectional study, hyperparathyroidism occurred more frequently in adults with a diet of high vs low inflammatory potential.
Patients on hemodialysis who have secondary hyperparathyroidism experienced a 40% reduction in PTH levels over 12 months of etelcalcetide treatment, investigators reported.